AlphaStocks
5.2
Consider Buy

Pfizer Inc (PFE)

As of Sep 20, 2026, Pfizer Inc (PFE) scores 5.2/10 on AlphaStocks' five-model composite, #102 of 168 Health Care stocks. At $28, PFE trades 17% below its model fair value of $33.

Health Care / Pharmaceuticals

S&P 500

$27.60

Below average on several measures. Research carefully.

Consider Buy

Score based on 5 of 5 models — high confidence

Data as of Sep 20, 2026

#102out of 168 in Health Care

Is PFIZER INC a Good Investment in 2026?

PFIZER INC (PFE) scores 5.2 out of 10 on AlphaStocks' composite model, earning a Consider Buy rating. The Greenblatt Magic Formula model rates PFIZER INC as Strong (Earnings yield 17.8% · ROC >100%). However, the Graham model rates it Caution — 12% above fair value. PFIZER INC currently trades 17% below its estimated fair value of $33. PFIZER INC ranks #102 out of 168 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

P/E20.3ROE8.7Market Cap158BDiv Yield7.1

Estimated Fair Value

$33.1217% below

Trading below estimated fair value. P/E of 20x is moderate for this quality level.

Model-based estimate, not a price target.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Attractive

5/9

Buffett

Attractive

Business quality & competitive moat

Graham

Caution

12% above fair value

Lynch

Neutral

High PEG — growth premium · Slow Grower

Greenblatt

Strong

Earnings yield 17.8% · ROC >100%

Frequently Asked Questions

Is PFIZER INC (PFE) a good investment?
As of Sep 20, 2026, Pfizer Inc (PFE) scores 5.2/10 on AlphaStocks' five-model composite, #102 of 168 Health Care stocks. At $28, PFE trades 17% below its model fair value of $33. That score is below average, suggesting caution.
What is PFIZER INC's Piotroski F-Score?
PFIZER INC's Piotroski F-Score status is Attractive. The raw score is 5/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is PFE overvalued or undervalued?
Based on AlphaStocks' model-based fair value estimate of $33, PFE appears undervalued. The stock currently trades 17% below its estimated fair value. Trading below estimated fair value. P/E of 20x is moderate for this quality level.
How does PFE compare to other Health Care stocks?
PFIZER INC ranks #102 out of 168 stocks in the Health Care sector, placing it in the top 61% of its sector by composite score. There are higher-ranked alternatives in this sector worth exploring.
What do investment models say about PFE?
AlphaStocks evaluates PFE using five proven investment models. Piotroski: Attractive; Buffett: Attractive; Graham: Caution; Lynch: Neutral; Greenblatt Magic Formula: Strong. These models are combined into a single composite score of 5.2/10.

Similar Stocks

AMPHLLYACAD

Compare PFE with

AMPH vs PFELLY vs PFEACAD vs PFEAZN vs PFEPFE vs VAL

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer